ZURICH & DUESSELDORF, Germany--(BUSINESS WIRE)-- Promising biotechs will have a unique opportunity to pitch their best assets to a star-studded panel of business development executives in a special competition at BIO-Europe® 2011, being held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany.
In the workshop, “The Perfect Pitch: Biotech Has Talent,” attendees will have a chance to win a one-to-one meeting with senior big pharma executives. Members of the audience will have 30 seconds to present their companies or technologies to global dealmakers, and will be judged on the quality and effectiveness of their overall pitches.
“The art of delivering your sales pitch succinctly is a very important skill, especially in an industry like biotechnology that relies heavily on relationships for partnering and fundraising,” said Doug MacDougall, President of MacDougall Biomedical Communications and moderator of the workshop. “This workshop provides a unique opportunity for companies with products, technologies or services to hone their skills in front of an audience of real decision makers.”
The top picks will be selected for a second round that includes an additional two to three minutes of presentation and/or a Q&A time with the panel. The first-place winner will receive a full 30-minute private follow-up meeting with the panelist of their choice.
“The ’Biotech Has Talent’ workshop is one of many interactive sessions at BIO-Europe that stimulate partnerships and build relationships among the nearly 3,000 attendees who are there to do business,” said Carola Schropp, President of EBD Group, the conference organizer. “We’re looking forward to both the pitches from companies and the viewpoints from the judges.”
Judges will come from a full range of companies including Merck Serono Ventures, Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Bayer, Shire and Genentech. Attendees are encouraged to practice thoroughly and pre-workshop coaching is available from MacDougall.
“Thirty seconds is more than enough time to deliver your message,” says MacDougall. “Your only goal is to get the next meeting, which of course is the prize we offer the winning contestants.”
BIO-Europe is Europe's largest partnering event serving the global biotechnology industry. BIO-Europe 2010 saw 14,661 one-to-one meetings conducted by 2,906 attendees from 1,688 companies. The event features partneringONE®, the industry's most advanced web-based partnering system, enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
For more information on pre-workshop coaching, contact Doug MacDougall at [email protected].
For more information on BIO-Europe: visit www.ebdgroup.com/bioeurope
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.
Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
Tilton Little, +1 415-410-5410
KEYWORDS: Europe Germany Switzerland
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical